Genetic Susceptibility to Chagas disease: An overview about the infection and about the association between disease and the immune response genes

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Ayo, Christiane Maria ^a   Dalalio, Márcia Machado De Oliveira ^a   Visentainer, Jeane Eliete Laguila ^a   Reis, Pâmela Guimarães ^a   Sippert, Emília Ângela ^a   Jarduli, Luciana Ribeiro ^a   Alves, Hugo Vicentin ^a   Sell, Ana Maria ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CHLORDANE; GAMMA INTERFERON; HLA B39 ANTIGEN; HLA B40 ANTIGEN; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 4; INTERLEUKIN 7; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MACROPHAGE MIGRATION INHIBITION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; BLOOD TRANSFUSION; CD4 CD8 RATIO; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEFORESTATION; DISEASE CARRIER; DISEASE COURSE; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FOOD CONTAMINATION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART ARRHYTHMIA; HEMAGGLUTINATION TEST; HEREDITY; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE GENE; IMMUNOFLUORESCENCE TEST; INFLAMMATION; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MORTALITY; NEGLECTED DISEASE; NONHUMAN; ORGAN TRANSPLANTATION; PARASITE TRANSMISSION; POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVIEW; RURAL POPULATION; SEROLOGY; SEXUAL TRANSMISSION; SOUTH AND CENTRAL AMERICA; SPLENOMEGALY; TRYPANOSOMA CRUZI; URBAN POPULATION; WOUND; XENODIAGNOSIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HOST PARASITE INTERACTION; IMMUNITY; IMMUNOLOGY; PARASITOLOGY; PATHOLOGY;

CHAGAS DISEASE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNITY; POLYMORPHISM, GENETIC;

EID: 84884273906     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/284729     Document Type: Review

References (147)

1. Chagas C., Nova tripanozomiaze humana. Estudos sobre a morfologia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp. Agente etiológico Agente etiológico de uma nova entidade mórbida para o homem. Memórias do Instituto Oswaldo Cruz 1909 1 159 218
2. Macedo A. M., Pena S. D. J., Genetic variability of Trypanosoma cruzi: implications for the pathogenesis of Chagas disease. Parasitology Today 1998 14 3 119 124 2-s2.0-0032032285 10.1016/S0169-4758(97)01179-4
3. Andrade L. O., Machado C. R. S., Chiari E., Pena S. D. J., Macedo A. M., Differential tissue distribution of diverse clones of Trypanosoma cruzi in infected mice. Molecular and Biochemical Parasitology 1999 100 2 163 172 2-s2.0-0032940097 10.1016/S0166-6851(99)90035-X
4. World Health Organization (2012) Chagas disease (American trypanosomiasis): Fact Sheet No 340
5. Kirchhoff L. V., Changing epidemiology and approaches to therapy for Chagas disease. Current Infectious Disease Reports 2003 5 1 59 65 2-s2.0-1242326006
6. Hoare C., The trypanosomes of mammals. Journal of Small Animal Practice 1972 13 671 672
7. Schofield C. J., Schofield C. J., Ponce C., Overview: evolution of the triatominae. Proceedings of the 2nd International Workshop on Population Genetics and Control of Triatominae 1998 Tegucigalpa, Honduras INDRE
8. Rothhammer F., Allison M. J., Nunez L., Standen V., Arriaza B., Chagas disease in pre-Columbian South America. American Journal of Physical Anthropology 1985 68 4 495 498 2-s2.0-0022358249
9. Coura J. R., Chagas disease: what is known and what is needed-a background article. Memorias do Instituto Oswaldo Cruz 2007 102 1 113 122 2-s2.0-36348992108
10. Aufderheide A. C., Salo W., Madden M., Streitz J., Buikstra J., Guhl F., Arriaza B., Renier C., Wittmers L. E. Jr., Fornaciari G., Allison M., A 9,000-year record of Chagas disease. Proceedings of the National Academy of Sciences of USA 2004 101 7 2034 2039 2-s2.0-10744233073 10.1073/pnas.0307312101
11. Carlier Y., Dias J. C. P., Luquetti A. O., Honteberye M., Torrico F., Truyens C., Trypanosomiase américaine ou maladie de Chagas. Encyclopedie Médico Chirurgicale 2002 Paris, Frence Elsevier
12. Bean W. B., The illness of Charles Darwin. The American Journal of Medicine 1978 65 4 572 574 2-s2.0-0018027891
13. Köberle F., 50 Years of Chagas' disease. Munchener Medizinische Wochenschrift 1957 99 1193 1198
14. Moncayo A., Ortiz Yanine M. I., An update on Chagas disease (human American trypanosomiasis). Annals of Tropical Medicine and Parasitology 2006 100 8 663 677 2-s2.0-34250635871 10.1179/136485906X112248
15. Schmunis G. A., Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Memorias do Instituto Oswaldo Cruz 2007 102 1 75 85 2-s2.0-36348949834
16. Schmunis G. A., Yadon Z. E., Chagas disease: a Latin American health problem becoming a world health problem. Acta Tropica 2010 115 1-2 14 21 2-s2.0-77953028103 10.1016/j.actatropica.2009.11.003
17. Coura J. R., Vinãs P. A., Chagas disease: a new worldwide challenge. Nature 2010 465 7301 S6 S7 2-s2.0-77954187759 10.1038/nature09221
18. Henao-Martínez A. F., Schwart D. A., Yang I. V., Chagasic cardiomyopathy, from acute to chronic: is this mediated by host susceptibility factors? Transactions of the Royal Society of Tropical Medicine and Hygiene 2012 106 9 521- 527
19. Neves D. P., Melo A. L., Genaro O., Parasitologia Humana 2005 São Paulo, Brazil Atheneu
20. Born D., Achá R. E. S., Ferraz M., Pregnancy and Chagas' disease. Journal of the American College of Cardiology 1998 31 421
21. Camandaroba E. L. P., Pinheiro Lima C. M., Andrade S. G., Oral transmission of Chagas disease: importance of Trypanosoma cruzi biodeme in the intragastric experimental infection. Revista do Instituto de Medicina Tropical de Sao Paulo 2002 44 2 97 103 2-s2.0-0036515898
22. Macedo A. M., Pena S. D. J., Genetic variability of Trypanosoma cruzi: implications for the pathogenesis of Chagas disease. Parasitology Today 1998 14 3 119 124 2-s2.0-0032032285 10.1016/S0169-4758(97)01179-4
23. Moncayo A., Chagas disease: current epidemiological irends after the interruption of vectorial and transfusional transmission in the southern cone countries. Memorias do Instituto Oswaldo Cruz 2003 98 5 577 591 2-s2.0-0142197130
24. Silva L. J., A evolução da doença de Chagas no Estado de São Paulo 1999 São Paulo, Brazil Editora Hucitec
25. Dutra W. O., Gollob K. J., Current concepts in immunoregulation and pathology of human Chagas disease. Current Opinion in Infectious Diseases 2008 21 3 287 292 2-s2.0-42949140355 10.1097/QCO.0b013e3282f88b80
26. Barrett M. P., Burchmore R. J. S., Stich A., Lazzari J. O., Frasch A. C., Cazzulo J. J., Krishna S., The trypanosomiases. The Lancet 2003 362 9394 1469 1480 2-s2.0-0242298279 10.1016/S0140-6736(03)14694-6
27. Brener Z., Pathogenesis and immunopathology of chronic Chagas disease. Memórias do Instituto Oswaldo Cruz 1987 82 205 213
28. Guhl F., Jaramillo C., Carranza J. C., Vallejo G. A., Molecular characterization and diagnosis of Trypanosoma cruzi and T. rangeli. Archives of Medical Research 2002 33 4 362 370 2-s2.0-0036661949 10.1016/S0188-4409(02) 00380-6
29. Moncayo A., Silveira A. C., Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Memorias do Instituto Oswaldo Cruz 2009 104 1 17 30 2-s2.0-68949203215
30. Moolani Y., Bukhman G., Hotez P. J., Neglected tropical diseases as hidden causes of cardiovascular disease. PLOS Neglected Tropical Diseases 2012 6 6, article e1499
31. Umezawa E. S., Luquetti A. O., Levitus G. P., Ponce C., Ponce E., Henriquez D., Revollo S., Espinoza B., Sousa O., Khan B., Da Silveira J. F., Serodiagnosis of chronic and acute Chagas' disease with Trypanosoma cruzi recombinant proteins: results of A Collaborative Study in six Latin American countries. Journal of Clinical Microbiology 2004 42 1 449 452 2-s2.0-9144266943 10.1128/JCM.42.1.449-452.2004
32. Afonso A. M., Ebell M. H., Tarleton R. L., A systematic review of high quality diagnostic tests for Chagas disease. PLOS Neglected Tropical Diseases 2012 6 11, article e1881
33. Dias E., Laranja F. S., Miranda A., Nobrega G., Chagas' disease; a clinical, epidemiologic, and pathologic study. Circulation 1956 14 6 1035 1060 2-s2.0-0000337841
34. Dutra W. O., Martins-Filho O. A., Cançado J. R., Activated T and B lymphocytes in peripheral blood of patients with Chagas disease. International Immunology 1994 6 499 506
35. Dutra W. O., Martins-Filho O. A., Cançado J. R., Pinto-Dias J. C., Brener Z., Gazzinelli G., Carvalho J. F., Colley D. G., Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scandinavian Journal of Immunology 1996 43 1 88 93 2-s2.0-0030026329
36. +B cells or activated T cells of chagasic patients, respectively. Scandinavian Journal of Immunology 2000 51 1 91 97 2-s2.0-0033957318 10.1046/j.1365-3083.2000.00648.x
37. Clark R. K., Kuhn R. E., Trypanosoma cruzi does not induce apoptosis in murine fibroblasts. Parasitology 1999 118 2 167 175 2-s2.0-0032918670 10.1017/S0031182098003631
38. Tarleton R. L., Trypanosoma cruzi -induced suppression of IL-2 production. II. Evidence for a role for suppressor cells. Journal of Immunology 1988 140 8 2769 2773 2-s2.0-0023924659
39. Rocha Rodrigues D. B., dos Reis M. A., Romano A., In situ expression of regulatory cytokines by heart inflammatory cells in Chagas' disease patients with heart failure. Clinical and Developmental Immunology 2012 2012 7 10.1155/2012/361730 361730
40. + T cells, the key to control Chagas' disease morbidity? Clinical and Experimental Immunology 2006 145 1 81 92 2-s2.0-33745136075 10.1111/j.1365-2249.2006.03123.x
41. Tarleton R. L., Grusby M. J., Postan M., Glimcher L. H., Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. International Immunology 1996 8 1 13 22 2-s2.0-0030051238 10.1093/intimm/8.1.13
42. Dutra W. O., Menezes C. A. S., Villani F. N. A., da Costa G. C., da Silveira A. B. M., Reis D. D., Gollob K. J., Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease. Memorias do Instituto Oswaldo Cruz 2009 104 supplement 1 208 218 2-s2.0-68949217385
43. + CD25High regulatory T lymphocytes. Scandinavian Journal of Immunology 2005 62 3 297 308 2-s2.0-26244455317 10.1111/j.1365-3083.2005.01668.x
44. + T cells at heart lesions of human chronic chagas disease cardiomyopathy. Scandinavian Journal of Immunology 2007 66 2-3 362 371 2-s2.0-34447319440 10.1111/j.1365-3083.2007.01987.x
45. Corrêa-Oliveira R., Gomes J. A. S., Lemos E. M., The role of the immune response on the development of severe clinical forms of human Chagas disease. Memórias do Instituto Oswaldo Cruz 1999 9 supplement 1 253 255
46. Goldenberg R. C., Iacobas D. A., Iacobas S., Rocha L. L., da Silva de Azevedo Fortes F., Vairo L., Nagajyothi F., Campos De Carvalho A. C., Tanowitz H. B., Spray D. C., Transcriptomic alterations in Trypanosoma cruzi -infected cardiac myocytes. Microbes and Infection 2009 11 14-15 1140 1149 2-s2.0-71649104746 10.1016/j.micinf.2009.08.009
47. Calvet C. M., Melo T. G., Garzoni L. R., Current understanding of the Trypanosoma cruzi -cardiomyocyte interaction. Frontiers in Immunology 2012 3 327
48. d'Avila Reis D., Lemos E. M., Silva G. C., Phenotypic characterization of the inflammatory cells in chagasic megaoesophagus. Transactions of the Royal Society of Tropical Medicine and Hygienee 2001 95 177 178
49. Da Silveira A. B., Adad S. J., Correa-Oliveira R., Furness J. B., d'Avila Reis D., Morphometric study of eosinophils, mast cells, macrophages and fibrosis in the colon of chronic chagasic patients with and without megacolon. Parasitology 2007 134 6 789 796 2-s2.0-34248349445 10.1017/S0031182007002296
50. Cardoso G. M., Morato M. J., Gomes J. A., Rocha M. O. C., Bonfim I. P., Williams-Blangero S., VandeBerg J. L., Reis M. R., Magalhães E. F. L., Correa-Oliveira R., Comparative analysis of cell phenotypes in different severe clinical forms of Chagas' disease. Frontiers in Bioscience 2006 11 1 1158 1163 2-s2.0-32844460181 10.2741/1870
51. Michailowsky V., Luhrs K., Rocha M. O., Fouts D., Gazzinelli R. T., Manning J. E., Humoral and cellular immune responses to Trypanosoma cruzi Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease. Infection and Immunity 2003 71 6 3165 3171 2-s2.0-0037767282 10.1128/IAI.71.6.3165-3171.2003
52. Vago A. R., Andrade L. O., Leite A. A., D'Avila Reis D., Macedo A. M., Adad S. J., Tostes S. J., Moreira M. D. C. V., Brasilerio Filho G., Pena S. D. J., Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic chagas disease: differential distribution of genetic types into diverse organs. American Journal of Pathology 2000 156 5 1805 1809 2-s2.0-0033835153
53. Dutra W. O., Menezes C. A. S., Villani F. N. A., da Costa G. C., da Silveira A. B. M., Reis D. D., Gollob K. J., Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease. Memorias do Instituto Oswaldo Cruz 2009 104 supplement 1 208 218 2-s2.0-68949217385
54. Schriefer A., Carvalho E. M., Biomarcadores em medicina. Gazeta Médica da Bahia 2008 78 47 51
55. FIOCRUZ. Polimorfismos genéticos e suscetibilidade a cardiopatia Chagásica, http://www.fiocruz.br/chagas/cgi/cgilua.exe/sys/start.htm?sid= 96
56. Mack D. G., Johnson J. J., Roberts F., Roberts C. W., Estes R. G., David C., Carl Grumet F., McLeod R., HLA-class II genes modify outcome of Toxoplasma gondii infection. International Journal for Parasitology 1999 29 9 1351 1358 2-s2.0-0032704229 10.1016/S0020-7519(99)00152-6
57. Fernandez-Mestre M. T., Layrisse Z., Montagnani S., Acquatella H., Catalioti F., Matos M., Balbas O., Makhatadze N., Dominguez E., Herrera F., Madrigal A., Influence of the HLA class II polymorphism in chronic Chagas' disease. Parasite Immunology 1998 20 4 197 203 2-s2.0-15644371732
58. Colorado I. A., Acquatella H., Catalioti F., Fernandez M. T., Layrisse Z., HLA class II DRB1, DQB11, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection. Human Immunology 2000 61 3 320 325 2-s2.0-0033999353 10.1016/S0198-8859(99)00177-9
59. Layrisse Z., Fernandez M. T., Montagnani S., Matos M., Balbas O., Herrera F., Colorado I. A., Catalioti F., Acquatella H., HLA-C*03 is a risk factor for cardiomyopathy in Chagas disease. Human Immunology 2000 61 9 925 929 2-s2.0-0033623378 10.1016/S0198-8859(00)00161-0
60. Llop E., Rothhammer F., Acuña M., Apt W., HLA antigens in cardiomyopathic Chilean chagasics. American Journal of Human Genetics 1988 43 5 770 773 2-s2.0-0023787192
61. Llop E., Rothhammer F., Acuña M., Apt W., Arribada A., HLA antigens in Chagas cardiomyopathy: new evidence based on a case-control study. Revista Medica De Chile 1991 119 6 633 636 2-s2.0-0026174491
62. Sierp G. M., Albert E. D., Gorodezky C., Sierp G., Albert E., Analysis of the HLA data. Proceedings of the 5th Latin American Histocompatibility Workshop 1992 Immunogenetics Laboratory
63. Deghaide N. H., Dantas R. O., Donadi E. A., HLA class I and II profiles of patients presenting with Chagas' disease. Digestive Diseases and Sciences 1998 43 2 246 252 2-s2.0-0031952631 10.1023/A:1018829600200
64. De Oliveira Dalálio M. M., Laguila Visentainer J. E., Moliterno R. A., Sell A. M., Petzel-Erler M. L., Association of HLA-DR2 with chronic chagasic cardiopathy in a population at Paraná Northeast region, Brazil. Acta Scientiarum 2002 24 727 730 2-s2.0-0036626652
65. Faé K. C., Drigo S. A., Cunha-Neto E., Ianni B., Mady C., Kalil J., Goldberg A. C., HLA and β -myosin heavy chain do not influence susceptibility to Chagas' disease cardiomyopathy. Microbes and Infection 2000 2 7 745 751 2-s2.0-0033922971 10.1016/S1286-4579(00)00501-3
66. Nieto A., Beraún Y., Callado M. D., Caballero A., Alonso A., González A., Martín J., HLA haplotypes are associated with differential susceptibility to Trypanosoma cruzi infection. Tissue Antigens 2000 55 3 195 198 2-s2.0-0034013643 10.1034/j.1399-0039.2000.550301.x
67. Cruz-Robles D., Reyes P. A., Monteón-Padilla V. M., Ortiz-Muñiz A. R., Vargas-Alarcón G., MHC class I and class II genes in mexican patients with Chagas disease. Human Immunology 2004 65 1 60 65 2-s2.0-1142309878 10.1016/j.humimm.2003.10.008
68. Borrás S. G., Diez C., Cotorruelo C., Pellizon O., Biondi C., Beloscar J., Bottasso O., Racca A., HLA class II DRB1 polymorphism in Argentinians undergoing chronic Trypanosoma cruzi infection. Annals of Clinical Biochemistry 2006 43, part 3 214 216 2-s2.0-33646348988 10.1258/ 000456306776865205
69. Borrs S. G., Racca L., Cotorruelo C., Biondi C., Beloscar J., Racca A., Distribution of HLA-DRB1 alleles in argentinean patients with chagas' disease cardiomyopathy. Immunological Investigations 2009 38 3-4 268 275 2-s2.0-70350625017 10.1080/08820130902766589
70. del Puerto F., Nishizawa J. E., Kikuchi M., Roca Y., Avilas C., Gianella A., Lora J., Velarde F. U. G., Miura S., Komiya N., Maemura K., Hirayama K., Protective human leucocyte antigen haplotype, HLA-DRB1*01-B*14, against chronic Chagas disease in Bolivia. PLoS Neglected Tropical Diseases 2012 6 3, article e1587 2-s2.0-84859168486 10.1371/journal.pntd.0001587
71. Bauer S., Groh V., Wu J., Steinle A., Phillips J. H., Lanier L. L., Spies T., Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999 285 5428 727 729 2-s2.0-0033618504 10.1126/science.285.5428.727
72. Pardoll D. M., Immunology: stress, NK receptors, and immune surveillance. Science 2001 294 5542 534 536 2-s2.0-0035914132 10.1126/science.1066284
73. Steinle A., Li P., Morris D. L., Groh V., Lanier L. L., Strong R. K., Spies T., Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 2001 53 4 279 287 2-s2.0-0034924218 10.1007/s002510100325
74. Bahram S., Bresnahan M., Geraghty D. E., Spies T., A second lineage of mammalian major histocompatibility complex class I genes. Proceedings of the National Academy of Sciences of the United States of America 1994 91 14 6259 6263 2-s2.0-0028198760 10.1073/pnas.91.14.6259
75. Stephens H. A. F., MICA and MICB genes: can the enigma of their polymorphism be resolved? Trends in Immunology 2001 22 7 378 385 2-s2.0-0034923215 10.1016/S1471-4906(01)01960-3
76. Zwirner N. W., Fernández-Viña M. A., Stastny P., MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics 1998 47 2 139 148 2-s2.0-0031964604 10.1007/s002510050339
77. Zwirner N. W., Dole K., Stastny P., Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes. Human Immunology 1999 60 4 323 330 2-s2.0-0032915014 10.1016/S0198-8859(98)00128-1
78. Groh V., Steinle A., Bauer S., Spies T., Recognition of stress-induced MHC molecules by intestinal epithelial γ δ T cells. Science 1998 279 5357 1737 1740 2-s2.0-0032513388 10.1126/science.279.5357.1737
79. Aida K., Juarez S., Kikuchi M., HLA-B35 and MICA-A5 synergistically enhanced susceptibility to chagas heart disease. MHC 2000 7 63 70
80. Vilches C., Parham P., KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annual Review of Immunology 2002 20 217 251 2-s2.0-0036215134 10.1146/annurev.immunol.20.092501.134942
81. Boyton R. J., Altmann D. M., Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clinical and Experimental Immunology 2007 149 1 1 8 2-s2.0-34250158132 10.1111/j.1365-2249.2007.03424.x
82. Rajagopalan S., Long E. O., Understanding how combinations of HLA and KIR genes influence disease. Journal of Experimental Medicine 2005 201 7 1025 1029 2-s2.0-17144363242 10.1084/jem.20050499
83. Martin M. P., Gao X., Lee J.-H., Nelson G. W., Detels R., Goedert J. J., Buchbinder S., Hoots K., Vlahov D., Trowsdale J., Wilson M., O'Brien S. J., Carrington M., Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nature Genetics 2002 31 4 429 434 2-s2.0-0036699528 10.1038/ng934
84. Méndez A., Granda H., Meenagh A., Contreras S., Zavaleta R., Mendoza M. F., Izquierdo L., Sarmiento M. E., Acosta A., Middleton D., Study of KIR genes in tuberculosis patients. Tissue Antigens 2006 68 5 386 389 2-s2.0-33750727692 10.1111/j.1399-0039.2006.00685.x
85. Franceschi D. S., Mazini P. S., Rudnick C. C., Sell A. M., Tsuneto L. T., De Melo F. C., Braga M. A., Peixoto P. R. F., Visentainer J. E. L., Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. Tissue Antigens 2008 72 5 478 482 2-s2.0-54049150355 10.1111/j.1399-0039.2008.01127.x
86. Marangon A. V., Silva G. F., De Moraes C. F., Grotto R. M. T., Pardini M. I. D. M. C., De Pauli D. S., Sell A. M., Visentainer J. E. L., Moliterno R. A., KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C. Human Immunology 2011 72 11 1074 1078 2-s2.0-80054118036 10.1016/j.humimm.2011.08.017
87. Alter G., Heckerman D., Schneidewind A., HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 2011 476 7358 96 100
88. Yindom L.-M., Forbes R., Aka P., Janha O., Jeffries D., Jallow M., Conway D. J., Walther M., Killer-cell immunoglobulin-like receptors and malaria caused by Plasmodium falciparum in the Gambia. Tissue Antigens 2012 79 2 104 113 2-s2.0-84855513987 10.1111/j.1399-0039.2011.01818.x
89. Lu C., Bai X. L., Shen Y. J., Potential implication of activating killer cell immunoglobulin-like receptor and HLA in onset of pulmonary tuberculosis. Scandinavian Journal of Immunology 2012 76 5 491 496
90. Yen J.-H., Moore B. E., Nakajima T., Scholl D., Schaid D. J., Weyand C. M., Goronzy J. J., Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. Journal of Experimental Medicine 2001 193 10 1159 1167 2-s2.0-0035927054 10.1084/jem.193.10.1159
91. Ramírezs-De los Santos S., Sánchez-Hernández P. E., Muñoz-Valle J. F., Associations of killer cell immunoglobulin-like receptor genes with rheumatoid arthritis. Disease Markers 2012 33 4 201 206
92. Kuśnierczyk P., Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms. Frontiers in Immunology 2013 10.3389/fimmu.2013.00008
93. Carrington M., Norman P., The KIR gene cluster. 2003, http://www.ncbi.nlm.nih.gov/books/bookres.fcgi/mono-003/ch1d1.pdf
94. Ashouri E., Dabbaghmanesh M. H., Rowhanirad S., Bakhshayeshkaram M., Omrani G. R., Ghaderi A., Activating KIR2DS5 receptor is a risk for thyroid cancer. Human Immunology 2012 73 10 1017 1022 10.1016/j.humimm.2012.07.325
95. Wiśniewski A., Jankowska R., Passowicz-Muszyńska E., KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a polish caucasian population. Human Immunology 2012 73 9 927 31 10.1016/j.humimm.2012.07.323
96. Franceschi D. S., De Souza C. A., Aranha F. J., Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation. Revista Brasileira de Hematologia e Hemoterapia 2011 33 2 126 130
97. Cox E. D., Hoffmann S. C., Dimercurio B. S., Wesley R. A., Harlan D. M., Kirk A. D., Blair P. J., Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation 2001 72 4 720 726 2-s2.0-0035959394
98. Wilson A. G., Symons J. A., Mcdowell T. L., Mcdevitt H. O., Duff G. W., Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America 1997 94 7 3195 3199 2-s2.0-0030954180 10.1073/pnas.94.7.3195
99. Pravica V., Asderakis A., Perrey C., Hajeer A., Sinnott P. J., Hutchinson I. V., In vitro production of IFN- γ correlates with CA repeat polymorphism in the human IFN- γ gene. European Journal of Immunogenetics 1999 26 1 1 3 2-s2.0-0032969945 10.1046/j.1365-2370.1999.00122.x
100. Awad M. R., El-Gamel A., Hasleton P., Turner D. M., Sinnott P. J., Hutchinson I. V., Genotypic variation in the transforming growth factor- β 1 gene: Association with transforming growth factor- β 1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998 66 8 1014 1020 2-s2.0-0032573136 10.1097/00007890- 199810270-00009
101. Turner D. M., Williams D. M., Sankaran D., Lazarus M., Sinnott P. J., Hutchinson I. V., An investigation of polymorphism in the interleukin-10 gene promoter. European Journal of Immunogenetics 1997 24 1 1 8 2-s2.0-0031017238
102. Franceschi D. S., Mazini P. S., Rudnick C. C. C., Sell A. M., Tsuneto L. T., Ribas M. L., Peixoto P. R., Visentainer J. E. L., Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil. International Journal of Infectious Diseases 2009 13 4 493 498 2-s2.0-67349185555 10.1016/j.ijid.2008.08.019
103. -174GC genotype in dengue fever. The Open Tropical Medicine Journal 2008 1 87 91
104. Bidwell J., Keen L., Gallagher G., Kimberly R., Huizinga T., McDermott M. F., Oksenberg J., McNicholl J., Pociot F., Hardt C., D'Alfonso S., Cytokine gene polymorphism in human disease: On-line databases. Genes and Immunity 1999 1 1 3 19 2-s2.0-0033188361
105. Vasconcelos R. H., Montenegro S. M., Azevedo E. A., Gomes Y. M., Morais C. N., Genetic susceptibility to chronic Chagas disease: an overview of single nucleotide polymorphisms of cytokine genes. Cytokine 2012 59 2 203 208 10.1016/j.cyto.2012.04.035
106. Beraún Y., Nieto A., Collado M. D., González A., Martín J., Polymorphisms at tumor necrosis factor (TNF) loci are not associated with Chagas' disease. Tissue Antigens 1998 52 1 81 83 2-s2.0-0031869303
107. Drigo S. A., Cunha-Neto E., Ianni B., Mady C., Faé K. C., Buck P., Kalil J., Goldberg A. C., Lack of association of tumor necrosis factor- α polymorphisms with Chagas disease in Brazilian patients. Immunology Letters 2007 108 1 109 111 2-s2.0-33845792965 10.1016/j.imlet.2006.10.008
108. Rodríguez-Pérez J. M., Cruz-Robles D., Hernández- Pacheco G., Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Immunology Letters 2005 98 1 97 102
109. Pissetti C. W., Correia D., De Oliveira R. F., Llaguno M. M., Balarin M. A. S., Silva-Grecco R. L., Rodrigues V. Jr., Genetic and functional role of TNF-alpha in the development Trypanosoma cruzi infection. PLoS Neglected Tropical Diseases 2011 5 3, article e976 2-s2.0-79953767552 10.1371/journal. pntd.0000976
110. Criado L., Flórez O., Martín J., González C. I., Genetic polymorphisms in TNFA/TNFR2 genes and Chagas disease in a Colombian endemic population. Cytokine 2012 57 3 398 401 2-s2.0-84856377294 10.1016/j.cyto.2011.12.007
111. Campelo V., Dantas R. O., Simões R. T., NF microsatellite alleles in Brazilian Chagasic patients. Digestive Diseases and Sciences 2007 12 3334 3349
112. Drigo S. A., Cunha-Neto E., Ianni B., Cardoso M. R. A., Braga P. E., Faé K. C., Nunes V. L., Buck P., Mady C., Kalil J., Goldberg A. C., TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes and Infection 2006 8 3 598 603 2-s2.0-33746292693 10.1016/j.micinf.2005.08.009
113. Ramasawmy R., Fae K. C., Cunha-Neto E., Müller N. G., Cavalcanti V. L., Ferreira R. C., Drigo S. A., Ianni B., Mady C., Goldberg A. C., Kalil J., Polymorphisms in the gene for lymphotoxin- α predispose to chronic chagas cardiomyopathy. Journal of Infectious Diseases 2007 196 12 1836 1843 2-s2.0-39149138134 10.1086/523653
114. Torres O. A., Calzada J. E., Beraún Y., Morillo C. A., González A., González C. I., Martín J., Lack of association between IL-6 -174G/C gene polymorphism and Chagas disease. Tissue Antigens 2010 76 2 131 134 2-s2.0-77954322159 10.1111/j.1399-0039.2010.01478.x
115. Cruz-Robles D., Chávez-González J. P., Cavazos-Quero M. M., Pérez-Méndez O., Reyes P. A., Vargas-Alarcón G., Association between IL-1B and IL-1RN gene polymorphisms and Chagas' disease development susceptibility. Immunological Investigations 2009 38 3-4 231 239
116. Flórez O., Zafra G., Morillo C., Martín J., González C. I., Interleukin-1 gene cluster polymorphism in Chagas disease in a Colombian Case-Control Study. Human Immunology 2006 67 9 741 748 2-s2.0-33748928028 10.1016/j.humimm.2006.06.004
117. D'Ávila D. A., Guedes P. M. M., Castro A. M., Gontijo E. D., Chiari E., Galvão L. M. C., Immunological imbalance between IFN- γ and IL-10 levels in the sera of patients with the cardiac form of Chagas disease. Memorias do Instituto Oswaldo Cruz 2009 104 1 100 105 2-s2.0-62749151026
118. Roffê E., Rothfuchs A. G., Santiago H. C., Marino A. P. M. P., Ribeiro-Gomes F. L., Eckhaus M., Antonelli L. R. V., Murphy P. M., IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. Journal of Immunology 2012 188 2 649 660 2-s2.0-84856013800 10.4049/jimmunol.1003845
119. Costa G. C., Costa Rocha M. O., Moreira P. R., Menezes C. A. S., Silva M. R., Gollob K. J., Dutra W. O., Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. Journal of Infectious Diseases 2009 199 3 451 454 2-s2.0-58849121536 10.1086/596061
120. Flórez O., Martín J., González C. I., Interleukin 4, interleukin 4 receptor- α and interleukin 10 gene polymorphisms in Chagas disease. Parasite Immunology 2011 33 9 506 511
121. Moreno M., Silva E. L., Ramírez L. E., Palacio L. G., Rivera D., Arcos-Burgos M., Chagas' disease susceptibility/resistance: linkage disequilibrium analysis suggest epistasis between major histocompatibility complex and interleukin-10. Tissue Antigens 2004 64 1 18 24 2-s2.0-3042780037 10.1111/j.1399-0039.2004.00260.x
122. Torres O. A., Calzada J. E., Beraún Y., Morillo C. A., González A., González C. I., Martín J., Role of the IFNG +874T/A polymorphism in Chagas disease in a Colombian population. Infection, Genetics and Evolution 2010 10 5 682 685 2-s2.0-77953189157 10.1016/j.meegid. 2010.03.009
123. Soares M. B. P., Silva-Mota K. N., Lima R. S., Bellintani M. C., Pontes-de-Carvalho L., Ribeiro-dos-Santos R., Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism. American Journal of Pathology 2001 159 2 703 709 2-s2.0-0034884975
124. Alvarado Arnez L. E., Venegas E. N., Ober C., Thompson E. E., Sequence variation in the IL4 gene and resistance to Trypanosoma cruzi infection in Bolivians. Journal of Allergy and Clinical Immunology 2011 127 1 279 282 2-s2.0-78650913482 10.1016/j.jaci.2010.10.026
125. Araújo-Jorge T. C., Waghabi M. C., Bailly S., The TGF- β pathway as an emerging target for Chagas disease therapy. Clinical Pharmacology & Therapeutics 2012 92 5 613 621
126. Calzada J. E., Beraún Y., González C. I., Martín J., Transforming growth factor beta 1 (TGF β 1) gene polymorphisms and Chagas disease susceptibility in Peruvian and Colombian patients. Cytokine 2009 45 3 149 153 2-s2.0-60649121513 10.1016/j.cyto.2008.11.013
127. Zafra G., Morillo C., Martín J., González A., González C. I., Polymorphism in the 3′ UTR of the IL12B gene is associated with Chagas' disease cardiomyopathy. Microbes and Infection 2007 9 9 1049 1052 2-s2.0-34548132097 10.1016/j.micinf.2007.04.010
128. Torres O. A., Calzada J. E., Beraún Y., Morillo C. A., González C. I., González A., Martín J., Association of the macrophage migration inhibitory factor -173G/C polymorphism with Chagas disease. Human Immunology 2009 70 7 543 546 2-s2.0-67449149682 10.1016/j.humimm.2009.04. 022
129. Nogueira L. G., Santos R. H. B., Ianni B. M., Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10. PLOS Neglected Tropical Diseases 2012 6 10, article e1867 10.1371/journal.pntd.0001867
130. Flórez O., Javier Martín J., González C. I., Genetic variants in the chemokines and chemokine receptors in Chagas disease. Human Immunology 2012 73 852 858
131. Calzada J. E., Nieto A., Beraún Y., Martín J., Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 2001 58 3 154 158 2-s2.0-0035174251 10.1034/j.1399-0039.2001.580302.x
132. Fernández-Mestre M. T., Montagnani S., Layrisse Z., Is the CCR5-59029-G/G genotype a protective factor for cardiomyopathy in Chagas disease? Human Immunology 2004 65 7 725 728 2-s2.0-4043112754 10.1016/j.humimm.2004.05.002
133. Ramasawmy R., Cunha-Neto E., Faé K. C., Martello F. G., Müller N. G., Cavalcanti V. L., Iaani B., Mady C., Kalil J., Goldberg A. C., The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human Chagas disease. Clinical Infectious Diseases 2006 43 3 305 311 2-s2.0-33746097383 10.1086/505395
134. Ramasawmy R., Cunha-Neto E., Faé K. C., Müller N. G., Cavalcanti V. L., Drigo S. A., Ianni B., Mady C., Kalil J., Goldberg A. C., BAT1, a putative anti-inflammatory gene, is associated with chronic chagas cardiomyopathy. Journal of Infectious Diseases 2006 193 10 1394 1399 2-s2.0-33646350509 10.1086/503368
135. Williams-Blangero S., Vandeberg J. L., Subedi J., Aivaliotis M. J., Rai D. R., Upadhayay R. P., Jha B., Blangero J., Genes on chromosomes 1 and 13 have significant effects on Ascaris infection. Proceedings of the National Academy of Sciences of the United States of America 2002 99 8 5533 5538 2-s2.0-0037117464 10.1073/pnas.082115999
136. Marquet S., Abel L., Hillaire D., Dessein H., Kalil J., Feingold J., Weissenbach J., Dessein A. J., Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nature Genetics 1996 14 2 181 184 2-s2.0-0029842548 10.1038/ng1096-181
137. Zhang F. R., Huang W., Chen S. M., Genomewide association study of leprosy. The New England Journal of Medicine 2009 361 27 2609 2618 10.1056/NEJMoa0903753
138. Thye T., Vannberg F. O., Wong S. H., Owusu-Dabo E., Osei I., Gyapong J., Sirugo G., Sisay-Joof F., Enimil A., Chinbuah M. A., Floyd S., Warndorff D. K., Sichali L., Malema S., Crampin A. C., Ngwira B., Teo Y. Y., Small K., Rockett K., Kwiatkowski D., Fine P. E., Hill P. C., Newport M., Lienhardt C., Adegbola R. A., Corrah T., Ziegler A., African TB Genetics Consortium A. T. G. C., Wellcome Trust Case Control Consortium W. T. C. C. C., Morris A. P., Meyer C. G., Horstmann R. D., Hill A. V. S., Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nature Genetics 2010 42 9 739 741 2-s2.0-77956635151 10.1038/ng.639
139. Mahasirimongkol S., Yanai H., Mushiroda T., Genome-wide association studies of tuberculosis in Asians identify distinct at-risk locus for young tuberculosis. Journal of Human Genetics 2012 57 6 363 367 10.1038/jhg.2012.35
140. Jallow M., Teo Y. Y., Small K. S., Genome-wide and fine-resolution association analysis of malaria in West Africa. Nature Genetics 2009 41 6 657 665 10.1038/ng.388
141. Khor C. C., Chau T. N. B., Pang J., Davila S., Long H. T., Ong R. T. H., Dunstan S. J., Wills B., Farrar J., Van Tram T., Gan T. T., Binh N. T. N., Tri L. T., Lien L. B., Tuan N. M., Tham N. T. H., Lanh M. N., Nguyet N. M., Hieu N. T., Van N Vinh Chau N., Thuy T. T., Tan D. E. K., Sakuntabhai A., Teo Y.-Y., Hibberd M. L., Simmons C. P., Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nature Genetics 2011 43 11 1139 1141 2-s2.0-80055010567 10.1038/ng.960
142. Rauch A., Kutalik Z., Descombes P., Cai T., Di Iulio J., Mueller T., Bochud M., Battegay M., Bernasconi E., Borovicka J., Colombo S., Cerny A., Dufour J.-F., Furrer H., Günthard H. F., Heim M., Hirschel B., Malinverni R., Moradpour D., Müllhaupt B., Witteck A., Beckmann J. S., Berg T., Bergmann S., Negro F., Telenti A., Bochud P.-Y., Genetic variation in IL28B Is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010 138 4 1338 1345 2-s2.0-77949831342 10.1053/j.gastro.2009.12.056
143. Kamatani Y., Wattanapokayakit S., Ochi H., Kawaguchi T., Takahashi A., Hosono N., Kubo M., Tsunoda T., Kamatani N., Kumada H., Puseenam A., Sura T., Daigo Y., Chayama K., Chantratita W., Nakamura Y., Matsuda K., A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nature Genetics 2009 41 5 591 595 2-s2.0-67349160018 10.1038/ng.348
144. Fellay J., Shianna K. V., Ge D., Colombo S., Ledergerber B., Weale M., Zhang K., Gumbs C., Castagna A., Cossarizza A., Cozzi-Lepri A., De Luca A., Easterbrook P., Francioli P., Mallal S., Martinez-Picado J., Miro J. M., Obel N., Smith J. P., Wyniger J., Descombes P., Antonarakis S. E., Letvin N. L., McMichael A. J., Haynes B. F., Telenti A., Goldstein D. B., A whole-genome association study of major determinants for host control of HIV-1. Science 2007 317 5840 944 947 2-s2.0-34548134145 10.1126/science.1143767
145. Fellay J., Ge D., Shianna K. V., Common genetic variation and the control of HIV-1 in humans. PLOS Genetics 2009 5 12, article e1000791 10.1371/journal.pgen.1000791
146. Pelak K., Goldstein D. B., Walley N. M., Host determinants of HIV-1 control in African Americans. Journal of Infectious Diseases 2010 201 8 1141 1149 2-s2.0-77954737374 10.1086/653735
147. Limou S., Le Clerc S., Coulonges C., Carpentier W., Dina C., Delaneau O., Labib T., Taing L., Sladek R., Deveau C., Ratsimandresy R., Montes M., Spadoni J.-L., Lelièvre J.-D., Lévy Y., Therwath A., Schächter F., Matsuda F., Gut I., Froguel P., Delfraissy J.-F., Hercberg S., Zagury J.-F., Meyer L., Broët P., Dalmasso C., Debré P., Théodorou I., Rouzioux C., Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS genomewide association study 02). Journal of Infectious Diseases 2009 199 3 419 426 2-s2.0-58849125366 10.1086/596067